Sunday, March 1, 2026

Cancer treatments canceled in Colima due to shortage of medications

Chemotherapy has been canceled at at least one public hospital in Colima due to a lack of cancer medications.

Cancer patient Perla Villa said Saturday that her chemotherapy appointment at the Mexican Social Security Institute (IMSS) General Hospital No. 1 in the municipality of Villa de Álvarez was canceled and that it was unclear when her treatment would resume.

“I have an appointment for tomorrow but sadly they called me this morning to tell me it would be canceled,” she said in a video posted to her Facebook account. “Why? Because there are no chemotherapy drugs.  … There are now definitely none … and they don’t know when there will be [more],” Villa said.

In a video filmed at the IMSS hospital, she said she had filed a complaint on her behalf and that of other patients in the same situation.

“It’s sad that they’re canceling our treatment and they’re telling me here that I’m not the only one who has made a complaint. Several people have come to make a complaint due to the same situation – the lack of medications,” Villa said.

“I please ask you to share this video so that it goes viral and we can receive our treatment as we deserve,” she said.

As of Monday afternoon, the video had been shared about 5,000 times and attracted over 600 comments.

“It’s not fair,” Villa said. “The government needs to get its act together so that there is medicine. I don’t know where the chain is broken … [but the cancer drugs] are not arriving where they should arrive, which is to each of us patients.”

A day before Villa posted her video, Twitter user Yadira Rocha said that her grandmother had been unable to access chemotherapy at the same hospital due to a shortage of paclitaxel, a medication used to treat a range of cancers.

The news website Publimetro reported that cancer patients in Colima have been complaining about drug shortages since July. IMSS hasn’t publicly addressed the issue.

For its part, state-owned medical company Birmex has acknowledged difficulties fulfilling the tasks the current federal government allocated to it: the purchasing and distribution of medications. Birmex said in a report that due to the “level of complexity” and a lack of resources it hasn’t concluded a project to develop a new national distribution system.

However, the state-owned company isn’t directly responsible for the lack of medications at the hospital in Villa de Álvarez as it was disqualified from an IMSS tendering process to find a distributor after it was deemed incapable of meeting the public health care provider’s needs.

Shortages of chemotherapy medications – especially those used to treat children with cancer – have plagued the government led by President López Obrador, who last year raised the possibility of using the army to get drugs to public health care facilities. AMLO has entrusted a range of non-traditional tasks to the military, but hasn’t – as yet – put it in charge of delivering drugs.

With reports from Publimetro and Reforma

Have something to say? Paid Subscribers get all access to make & read comments.
newspapers with El Mencho's face on the front page

Mexico’s week in review: The fall of El Mencho

6
Mexico's most wanted criminal is dead, his cartel is leaderless and the race to replace him has already begun — here's your guide to the week that changed Mexico's security landscape.
Mexican marines inspect a burned car in Puerto Vallarta

In the wake of another fallen cartel leader, 10 reasons why this time could be different: A perspective from our CEO

22
After the fall of a major cartel leader, conventional wisdom predicts more violence. Mexico News Daily's CEO makes the case for why this time could genuinely be different.
The Mexico City skyline with a skyscraper in the foreground

Mexico’s economic growth outlook improves as Banxico, OECD lift forecasts

1
Mexico's central bank and one of the world's leading economic organizations raised their 2026 GDP growth forecast to 1.6% and 1.4% respectively, offering cautious optimism after Mexico's sluggish 2025 performance
BETA Version - Powered by Perplexity